J&J, BMS arthritis drugs lowered death risk among COVID patients in federal studynews2022-06-02T19:42:15+00:00June 2nd, 2022|Fierce Pharma|
Pfizer’s new vaccine R&D leader Anderson has a high bar to reach in replacing Jansennews2022-06-02T16:36:41+00:00June 2nd, 2022|Fierce Pharma|
Moderna, EU officials delay COVID-19 vaccine deliveries as demand fallsnews2022-06-02T15:50:15+00:00June 2nd, 2022|Fierce Pharma|
Gilead names new manufacturing head in wake of recent hiccupsnews2022-06-02T14:26:48+00:00June 2nd, 2022|Fierce Pharma|
Regeneron pays Sanofi $900M for full rights to cancer drug Libtayo as it looks to become a force in oncologynews2022-06-02T14:20:37+00:00June 2nd, 2022|Fierce Pharma|
Bristol severs Russian ties as Novartis resurrects Ukraine business following safety reviewnews2022-06-02T14:12:27+00:00June 2nd, 2022|Fierce Pharma|
Sana Biotechnology ditches California manufacturing plans in bid to save $100Mnews2022-06-02T13:24:27+00:00June 2nd, 2022|Fierce Pharma|
Novartis’ surprise radiotherapy production halt nearing an end as FDA docs shed light on plant woesnews2022-06-02T12:47:14+00:00June 2nd, 2022|Fierce Pharma|
Pfizer shoots back at Alnylam’s claims in high-stakes COVID-19 vaccine patent casenews2022-06-02T12:44:42+00:00June 2nd, 2022|Fierce Pharma|
Nephron recalls 2.1M drug doses, devices on sterility concernsnews2022-06-02T12:36:20+00:00June 2nd, 2022|Fierce Pharma|
